Similar articles

• Binding of indomethacin to human serum albumin. Its non displacement by various agents, influence of free fatty acids and the unexpected effect of indomethacin on warfarin binding.

  Zini R, D'Athis P, Barre J, Tillement JP. Zini R, et al. Biochem Pharmacol. 1979 Sep 1;28(17):2661-5. doi: 10.1016/0006-2952(79)90043-1. Biochem Pharmacol. 1979. PMID: 518678 No abstract available.
• The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.

  Wosilait WD, Ryan MP. Wosilait WD, et al. Res Commun Chem Pathol Pharmacol. 1979 Sep;25(3):577-84. Res Commun Chem Pathol Pharmacol. 1979. PMID: 504792
• Warfarin-sulfinpyrazone interaction on binding to human serum albumin.

  Larsen FG, Larsen CG, Brodersen R. Larsen FG, et al. J Pharm Pharmacol. 1984 Oct;36(10):689-90. doi: 10.1111/j.2042-7158.1984.tb04845.x. J Pharm Pharmacol. 1984. PMID: 6150088
• Drug-protein binding: recent advances in methodology: spectroscopic techniques.

  Chignell CF. Chignell CF. Ann N Y Acad Sci. 1973 Nov 26;226:44-59. doi: 10.1111/j.1749-6632.1973.tb20467.x. Ann N Y Acad Sci. 1973. PMID: 4129140 Review. No abstract available.
• The location of drug binding sites in human serum albumin.

  Fehske KJ, Müller WE, Wollert U. Fehske KJ, et al. Biochem Pharmacol. 1981 Apr 1;30(7):687-92. doi: 10.1016/0006-2952(81)90151-9. Biochem Pharmacol. 1981. PMID: 7018498 Review. No abstract available.